Fig. 3: Forest plot of modeled cost comparisons between TuPro and control cohorts based on IPTW-weighted analyses and additional statistical adjustment for confounding.

Adverse events costs costs incurred by the treatment of adverse events, CI confidence interval, IPTW inverse probability of treatment weighting, total costs sum of treatment costs, adverse events costs and costs for diagnostics (i.e., TuPro multi-omics profiling vs. standard next generation molecular panel), TuPro Tumor Profiler project melanoma cohort.